Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 1/20 | 0.37 |
| ▸ | SLC6A12 | P48065 | 3/20 | 0.31 |
| ▸ | SLC6A11 | P48066 | 3/20 | 0.31 |
| ▸ | SLC6A13 | Q9NSD5 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16522348 | 0.82 | POLB (0.33) | — | |
| SCHEMBL16351613 | 0.80 | HSD11B1 (0.33) | HSD11B1 | |
| SCHEMBL16351591 | 0.75 | HSD11B1 (0.37) | HSD11B1SLC6A12SLC6A11SLC6A13 | |
| SCHEMBL12364331 | 0.72 | GABRR1 (0.37) | — | |
| SCHEMBL16522346 | 0.72 | HSD11B1 (0.35) | HSD11B1 | |
| SCHEMBL14944771 | 0.72 | GABRR1 (0.40) | — | |
| SCHEMBL12221572 | 0.70 | GABRR1 (0.32) | — | |
| SCHEMBL16351590 | 0.70 | POLB (0.36) | — | |
| SCHEMBL16351616 | 0.70 | HSD11B1 (0.33) | HSD11B1 | |
| SCHEMBL16351598 | 0.69 | GABRR1 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150056367-A1 | COMPOSITION FOR FORMING LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY ELEMENT | SOKI CORPORATION (JP) | 2015-02-26 | — | — | US | disclosed |
| US-20140378645-A1 | LIQUID CRYSTAL ALIGNING AGENT | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2014-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140378645-A1 | LIQUID CRYSTAL ALIGNING AGENT | CYP17A1, AUP1, NR5A1 | HSD11B1 224/4885SLC6A12 4470/4885SLC6A11 2852/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.